Eventide Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-270,000
| Closed | -$18M | – | 154 |
|
|
2018
Q1 | $18M | Sell |
270,000
-54,000
| -17% | -$3.6M | 0.84% | 42 |
|
|
2017
Q4 | $16.7M | Hold |
324,000
| – | – | 0.87% | 44 |
|
|
2017
Q3 | $28.9M | Buy |
324,000
+174,000
| +116% | +$15.5M | 1.64% | 21 |
|
|
2017
Q2 | $8.96M | Hold |
150,000
| – | – | 0.56% | 52 |
|
|
2017
Q1 | $8M | Hold |
150,000
| – | – | 0.53% | 54 |
|
|
2016
Q4 | $7.49M | Hold |
150,000
| – | – | 0.49% | 59 |
|
|
2016
Q3 | $9.01M | Hold |
150,000
| – | – | 0.55% | 52 |
|
|
2016
Q2 | $7.67M | Hold |
150,000
| – | – | 0.47% | 59 |
|
|
2016
Q1 | $4.43M | Hold |
150,000
| – | – | 0.25% | 81 |
|
|
2015
Q4 | $6.8M | Buy |
150,000
+101,000
| +206% | +$4.58M | 0.34% | 71 |
|
|
2015
Q3 | $2.05M | Buy |
49,000
+10,800
| +28% | +$451K | 0.12% | 99 |
|
|
2015
Q2 | $2.3M | Buy |
+38,200
| New | +$2.3M | 0.12% | 95 |
|